Three things to know:
1. The funding was provided by the Peer Reviewed Orthopedic Research Program of the U.S. Department of Defense.
2. The phase 1/2 clinical trial will study HST-003, a biologic product that regenerates tissue, in a microfracture procedure in 15 patients with focal cartilage defects in the knee.
3. OasisMD in San Diego, The Steadman Clinic in Vail, Colo., and Walter Reed Medical Center in Bethesda, Md., will serve as clinical sites for the trial.
More articles on biologics:
8 spine, orthopedic expansions costing $120M+
5 spine surgeons pioneering novel procedures — Drs. Justin Brown, Dror Paley & more
How Medtronic, Stryker, Johnson & Johnson’s shares performed this week
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
